[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2017 POC/Decentralized Clinical Chemistry and Immunodiagnostic Testing: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers--Supplier Shares and Strategies, Country Forecasts, Emerging Technologies, Instrumentation Review

March 2017 | 500 pages | ID: 21E11F52284EN
Venture Planning Group

US$ 7,650.00 US$ 8,500.00 -10 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
VPGMarketResearch.com's new report provides a comprehensive analysis of the POC clinical chemistry markets, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation
  • Review of the POC clinical chemistry and immunodiagnostic market segments, including their dynamics, trends, structure, size, growth and major suppliers.
  • Five-year test volume and reagent sales forecasts clinical chemistry procedures by market segment:
  • Physician Offices/Group Practices
  • Emergency Rooms
  • Operating/Recovery Suites
  • ICUs/CCUs
  • Cancer Clinics
  • Ambulatory Care Centers
  • Surgery Centers
  • Nursing Homes
  • Birth Centers
Sales and Market Share Analysis

Sales and market shares of major reagent and instrument suppliers.

Routine Clinical Chemistry Tests

Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST/SGOT, Bilirubin, Blood Gases, BUN (Blood Urea Nitrogen), Calcium, Cholesterol, Cholinesterase, Creatinine, CK-MB, Electrolytes (Carbon Dioxide/Bicarbonate, Chloride, Potassium, Sodium), Ferritin, Follate/Folic Acid, Fructosamine, GGT, Glucose, HDL, Iron, LDH, Magnesium, Phosphorus, Potassium, Protein, Sodium, Triglycerides, Troponin, Uric Acid, Urinalysis, Vitamin B12.

Endocrine Function Tests

Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone, TSH.

Therapeutic Drug Monitoring (TDM) Tests

Amikacin, Carbamazepine, Digoxin, Gentamicin, Lidocaine, Lithium, Methotrexate, Phenobarbital, Phenytoin/Dilatin, NAPA/Procainamide, Quinidine, Theophylline, Tobramycin, Valproic Acid, Vancomycin.

Immunoprotein Tests

C3, C4, CRP, IgA, IgE Specific, IgE Total, IgG, Immunoglobulins, Protein Electrophoresis, and others.

Drugs of Abuse

Amphetamines, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine, Propoxyphene, and others.

Technology Review
  • Emerging technologies and their applications for POC testing.
  • Comprehensive listings of companies developing or marketing POC diagnostic technologies and products, by test.
Strategic Recommendations
  • Specific opportunities for new POC instruments and reagent systems with potentially significant market appeal during the next five years.
  • Design criteria for POC testing products.
  • Alternative business expansion strategies.
  • Potential market entry barriers and risks.
Competitive Assessments
  • Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.
The companies analyzed in the report include:
  • Abbott
  • AdnaGen
  • Agilent Technologies
  • Beckman Coulter/Danaher
  • Biomedical Diagnostics/Theradiag
  • Biomerieux
  • Bio-Rad
  • Diasorin
  • Eiken Chemical
  • Fujirebio
  • Grifols
  • Instrumentation Laboratory
  • Kyowa Medex
  • Matritech/Alere
  • Ortho-Clinical Diagnostics
  • Quest Diagnostics
  • Roche
  • Siemens
  • Sysmex
  • Thermo Fisher
  • Tosoh
  • Wako
  • Wallac/PE

    Methodology

    This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and VPGMarketResearchs proprietary data files.

    Contains 500 pages and 129 tables
  • INTRODUCTION
    Executive Summary
    Rationale for Testing Decentralization


      1. OVERVIEW
      2. REGULATORY TRENDS
      3. ECONOMIC TRENDS
      4. DEMOGRAPHIC TRENDS
      5. TECHNOLOGICAL TRENDS
      6. SOCIAL TRENDS
      7. QUALITY OF CARE
      8. DEFENSIVE MEDICINE
      9. QUALITY CONTROL ISSUES
    Review of Clinical Chemistry Immunodiagnostic Tests
      1. ALBUMIN
      2. ALKALINE PHOSPHATASE
      3. ALT/SGPT
      4. AMMONIA
      5. AMYLASE
      6. AST/SGOT
      7. BILIRUBIN
      8. BLOOD GASES
      9. BLOOD UREA NITROGEN (BUN)
      10. CALCIUM
      11. CHOLESTEROL
      12. CHOLINESTERASE
      13. CREATININE
      14. ELECTROLYTES
        a. Carbon Dioxide/Bicarbonate
        b. Chloride
        c. Potassium
        d. Sodium
      15. FERRITIN
      16. FOLLATE/FOLIC ACID
      17. FRUCTOSAMINE
      18. GAMMA GLUTAMYL TRANSPEPTIDASE (GGT)
      19. GLUCOSE
      20. HIGH DENSITY LIPOPROTEIN (HDL)
      21. IRON
      22. LACTATE DEHYDROGENASE (LDH)
      23. MAGNESIUM
      24. PHOSPHORUS
      25. PROTEIN
      26. TRIGLYCERIDES
      27. TROPONIN
      28. URIC ACID
      29. URINALYSIS
      30. VITAMIN B12
    Endocrine Function Tests
      1. CORTISOL
      2. FOLLICLE    STIMULATING HORMONE (FSH)
      3. GASTRIN
      4. HUMAN CHORIONIC GONADOTROPIN (HCG)
      5. LH
      6. PROLACTIN
      7. T3
      8. T3 UPTAKE
      9. FREE T3
      10. THYROXINE (T4)
      11. FREE T4
      12. TBG
      13. TSH
    Therapeutic Drug Monitoring (TDM)
      1. OVERVIEW
      2. CARBAMAZEPINE
      3. DIGOXIN
      4. GENTAMICIN
      5. LIDOCAINE
      6. LITHIUM
      7. PHENYTOIN/DILANTIN
      8. PROCAINAMIDE
      9. QUINIDINE
      10. THEOPHYLLINE
      11. VALPROIC ACID
    Immunoprotein Tests
      1. CRP
      2. IMMUNOGLOBULINS
    Drugs of Abuse
      1. OVERVIEW
      2. TEST METHODOLOGIES
      3. AMPHETAMINES
      4. BARBITURATES
      5. BENZODIAZEPINES
      6. CANNABINOIDS/MARIJUANA
      7. COCAINE
      8. LYSERGIC ACID DIETHYLAMIDE (LSD)
      9. METHADONE
      10. METHAQUALONE
      11. OPIATES
      12. PHENCYCLIDINE
    Instrumentation: Chemistry Immunodiagnostic Analyzers
    Manufactured by : Abaxis
      Abbott
      Alfa Wassermann
      Awareness Technologies
      Beckman Coulter/Danaher
      bioMeriuex
      Carolina Chemistries
      Horiba
      Inverness
      Medica
      Nova Biomedical
      Ortho    Clinical Diagnostics
      Polimedco
      Randox
      Roche
    Current and Emerging Technologies
      1. MONOCLONAL ANTIBODIES
      2. IMMUNOASSAYS
        a. Technological Principle
        b. Enzyme Immunoassays (EIA)
          Overview
          ELISA
          Dot Immunobinding Assays
          Capillary Immunoassays
          Particle Membrane Capture Immunoassay
          Enzyme Amplification
        c. Fluorescent Immunoassays
          Fluorescent Polarization
          Time Resolved Pulse Fluorescence
        d. Luminescence
          Chemiluminescence
          Bioluminescence
        e. Latex Agglutination
        f. Immunoprecipitation
      3. DRY CHEMISTRY
      4. BIOSENSORS
      5. IT AND AUTOMATION
      6. MOLECULAR DIAGNOSTICS
        a. Technology Overview
        b. Amplification Methods
          Polymerase Chain Reaction
          Ligase Chain Reaction
          Branched DNA
          Q    Beta Replicase
          Strand Displacement Activation
          Self    Sustained Sequence Replicase

    U.S.A.

    A. Market Overview
      1. BUSINESS ENVIRONMENT
        a. Health Care Expenditures
        b. Cost Consciousness
        c. Reimbursement
        d. Industry Consolidation
        e. Managed Care
          PPO

          HMO

        f. Hospitals
        g. Admissions
        h. Length of Stay
        i. Industry Diversification
        j. Physician Demographics
        k. Aging Population
          More Chronic Illness
          Disease Incidence
          Susceptibility to latrogenesis
          Multiple Illnesses Cases
        l. Laboratory Regulations
      2. MARKET STRUCTURE
        a. Hospitals
        b. Commercial/Private Laboratories
    B. Physician Offices/Group Practices

    1. MARKET SUMMARY

      2. MARKET STRUCTURE
      3. TEST VOLUME AND SALES FORECASTS
    C. Ancillary Hospital Locations
      1. INTRODUCTION
        a. Emergency Departments   b. Operating Suites
        c. Intensive Care Units
      2. EMERGENCY DEPARTMENTS A. MARKET SUMMARY
        b. Test volume and Sales Forecasts
      3. OPERATING AND RECOVERY SUITES A. MARKET SUMMARY
        b. Test Volume and Sales Forecasts
      4. ICUS/CCUS
        a. Market Summary
        b. Test Volume and Sales Forecasts
    D. Cancer Clinics
      1. INTRODUCTION
      2. MARKET SUMMARY
      3. TEST VOLUME AND SALES FORECASTS
    E. Ambulatory Care Centers

    1. INTRODUCTION

      2. MARKET SUMMARY
      3. MARKET STRUCTURE
      4. TEST VOLUME AND SALES FORECASTS
    F. Surgery Centers

    1. INTRODUCTION

      2. MARKET SUMMARY
      3. MARKET STRUCTURE
      4. TEST VOLUME AND SALES FORECASTS
    G. Nursing Homes

    1. INTRODUCTION

      2. MARKET SUMMARY
      3. MARKET STRUCTURE
      4. TEST VOLUME AND SALES FORECASTS
    H. Birth Centers

    1. INTRODUCTION

      2. MARKET SUMMARY
      3. MARKET STRUCTURE
      4. TEST VOLUME AND SALES FORECASTS

    1. MAJOR SUPPLIERS’ SALES AND MARKET SHARES

    Germany
    A. Market Overview
    B. Market Structure
    C. Market Summary
    D. Test Volume and Sales Forecasts
    E. Major Suppliers’ Sales and Market Shares
    Spain
    A. Business Environment
    B. Market Structure
    C. Market Summary
    D. Test Volume and Sales Forecasts
    E. Major Suppliers’ Sales and Market Shares
    Major Product Development Opportunities
    A. Routine and Special Chemistry
    B. Microbiology/Infectious Diseases
    C. Hematology and Flow Cytometry
    D. Coagulation

    DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

    ALTERNATIVE MARKET PENETRATION STRATEGIES

    A. Internal Development
    B. Collaborative Arrangements
    C. University Contracts
    D. Distribution Strategies for Decentralized Testing Markets
      1. MARKETING APPROACHES
      2. PRODUCT COMPLEXITY
      3. CUSTOMER PREFERENCE
      4. ESTABLISHED SUPPLIERS
      5. EMERGING SUPPLIERS
      6. MAJOR TYPES OF DISTRIBUTORS
      7. MARKET SEGMENTATION

    POTENTIAL MARKET ENTRY BARRIERS AND RISKS

    A. Market Maturity
    B. Cost Containment
    C. Competition
    D. Technological Edge and Limitations
    E. Patent Protection
    F. Regulatory Constraints
    G. Decentralized Testing Market Challenges
    Company Profile
      Abbott Laboratories
      AdnaGen
      Agilent Technologies
      Beckman Coulter/Danaher
      Biomedical Diagnostics
      BioMerieux
      Bio-Rad
      DiaSorin
      Eiken
      Fujirebio
      Grifols
      Instrumentation Laboratory
      Kyowa Medex
      Matritech/Alere
      Ortho    Clinical Diagnostics
      Quest Diagnostics
      Roche
      Siemens
      Sysmex
      Thermo Fisher
      Tosoh
      Wako
      Wallac/PE

    LIST OF TABLES

    Major Companies Developing or Marketing Albumin Tests
    Major Companies Developing or Marketing Alkaline Phosphatase Tests
    Major Companies Developing or Marketing ALT/SGPT Tests
    Major Companies Developing or Marketing Amylase Tests
    Major Companies Developing or Marketing AST/SGOT Tests
    Major Companies Developing or Marketing Bilirubin Tests
    Major Companies Developing or Marketing Blood Gas Analyzers
    Major Companies Developing or Marketing BUN Tests
    Major Companies Developing or Marketing Calcium Tests
    Major Companies Developing or Marketing Cholesterol Tests
    Major Companies Developing or Marketing Creatinine Tests
    Major Companies Developing or Marketing Electrolyte Tests
    Major Companies Developing or Marketing Ferritin Tests
    Major Companies Developing or Marketing GGT Tests
    Major Companies Developing or Marketing Glucose Tests
    Major Companies Developing or Marketing HDL Tests
    Major Companies Developing or Marketing Iron Tests
    Major Companies Developing or Marketing LDH Tests
    Major Companies Developing or Marketing Magnesium Tests
    Major Companies Developing or Marketing Phosphorus Tests
    Major Companies Developing or Marketing Protein Tests
    Major Companies Developing or Marketing Triglycerides Tests
    Major Companies Developing or Marketing Uric Acid Tests
    Major Companies Developing or Marketing Vitamin B    12/Folate Tests
    Major Companies Developing or Marketing FSH Tests
    Major Companies Developing or Marketing HCG Tests
    Major Companies Developing or Marketing LH Tests
    Major Companies Developing or Marketing Prolactin Tests
    Major Companies Developing or Marketing T3 Tests
    Major Companies Developing or Marketing T4 Tests
    Major Companies Developing or Marketing TSH Tests
    Major Companies Developing or Marketing TDM Tests
    Major Companies Developing or Marketing Digoxin Tests
    Major Companies Developing or Marketing Lithium Tests
    Major Companies Developing or Marketing Phenytoin/Dilantin Tests
    Major Companies Developing or Marketing Theophylline Tests
    Major Companies Developing or Marketing Valproic Acid Tests
    Major Companies Developing or Marketing Drugs of Abuse Tests
    U.S.A., Office Based Physicians Forecast by Practice Type
    U.S.A., Physician Offices/Group Practices Forecast by Type
    U.S.A., Physician Office/Group Practice Laboratories Forecast by Practice Size
    U.S.A., Physician Offices/Group Practices Routine and Special Chemistry Test Volume Forecast
    U.S.A., Physician Offices/Group Practices TDM Test Volume Forecast
    U.S.A., Physician Offices/Group Practices Endocrine Function Test Volume Forecast
    U.S.A., Physician Offices/Group Practices Major Tumor Marker Test Volume Forecast
    U.S.A., Physician Offices/Group Practices Immunoprotien Test Volume Forecast
    U.S.A., Physician Offices/Group Practices Drugs of Abuse Test Volume Forecast
    U.S.A., Physician Offices/Group Practices Routine and Special Chemistry Test Volume Forecast by Practice Type
    U.S.A., Physician Offices/Group Practices TDM Test Volume Forecast by Practice Type
    U.S.A., Physician Offices/Group Practices Endocrine Function Test Volume Forecast by Practice Type
    U.S.A., Physician Offices/Group Practices Tumor Markers Test Volume Forecast by Practice Type
    U.S.A., Physician Offices/Group Practices Immunoprotein Test Volume Forecast by Practice Type
    U.S.A., Physician Offices/Group Practices Drugs of Abuse Test Volume Forecast by Practice Type
    U.S.A., Physician Offices/Group Practices Routine and Special Chemistry Reagent Market Forecast by Test
    U.S.A., Physician Offices/Group Practices TDM Reagent Market Forecast by Test
    U.S.A., Physician Offices/Group Practices Endocrine Function Reagent Market Forecast by Test
    U.S.A., Physician Offices/Group Practices Major Tumor Marker Reagent Market Forecast by Test
    U.S.A., Physician Offices/Group Practices Immunoprotein Reagent Market Forecast by Test
    U.S.A., Physician Offices/Group Practices Drugs of Abuse Reagent Market Forecast by Test
    U.S.A., Ancillary Hospital Locations Estimated Number
    U.S.A., Ancillary Hospital Locations Annual Utilization
    U.S.A., Hospital Emergency Departments Routine and Special Chemistry Test Volume Forecast
    U.S.A., Hospital Emergency Departments Profiles, Panels and Individual Tests
    U.S.A., Hospital Emergency Departments Drugs of Abuse Test Volume Forecast
    U.S.A., Hospital Emergency Departments Routine and Special Chemistry Reagent Market Forecast by Test
    U.S.A., Hospital Emergency Departments Drugs of Abuse Reagent Market Forecast by Test
    U.S.A., Hospital Operating and Recovery Suites Routine and Special Chemistry Reagent Test Volume Forecast
    U.S.A., Hospital Operating and Recovery Suites Routine and Special Chemistry Reagent Market Forecast by Test
    U.S.A., Hospital ICUs/CCUs Total Diagnostics Sales Forecast by Market Segment
    U.S.A., Hospital ICUs/CCUs Reagent Sales Forecast by Market Segment
    U.S.A., Hospital ICUs/CCUs Instrument Sales Forecast by Market Segment
    U.S.A., Hospital ICUs/CCUs Routine and Special Chemistry Test Volume Forecast
    U.S.A., Hospital ICUs/CCUs Routine and Special Chemistry Reagent Market Forecast by Test
    U.S.A., Cancer Clinics Routine And Special Chemistry Test Volume Forecast
    U.S.A., Cancer Clinics Endocrine Function Test Volume Forecast
    U.S.A., Cancer Clinics Routineand Special Chemistry Reagent Market Forecast by Test
    U.S.A., Cancer Clinics Endocrine Function Reagent Market Forecast
    U.S.A., Ambulatory Care Centers Estimated Number of Facilities and Patient Visits
    U.S.A., Ambulatory Care Centers Most Frequent Diagnoses
    U.S.A., Ambulatory Care Centers Routine and Special Chemistry Test Volume Forecast
    U.S.A., Ambulatory Care Centers Drugs of Abuse Test Volume Forecast
    U.S.A., Ambulatory Care Centers Routine and Special Chemistry Reagent Market Forecast by Test
    U.S.A., Ambulatory Care Centers Drugs of Abuse Reagent Market Forecast by Test
    U.S.A., Surgery Centers Most Frequently Performed Procedures
    U.S.A., Surgery Centers Routineand Special Chemistry Test Volume Forecast
    U.S.A., Surgery Centers Routineand Special Chemistry Reagent Market Forecast by Test
    U.S.A., Nursing Homes Estimated Number of Facilities, Beds and Occupancy Rate
    U.S.A., Nursing Homes Routineand Special Chemistry Test Volume Forecast
    U.S.A., Nursing Homes Routineand Special Chemistry Reagent Market Forecast by Test
    U.S.A., Birth Centers Facilities, Patient Visits, and Births
    U.S.A., Birth Centers Routineand Special Chemistry Test Volume Forecast
    U.S.A., Birth Centers Profiles, Panels and Individual Tests
    U.S.A., Birth Centers Routineand Special Chemistry Reagent Market Forecast by Test
    U.S.A., Major Suppliers of Clinical Chemistry Diagnostics Products, Estimated Sales and Market Shares
    U.S.A., Major Suppliers of Clinical Chemistry Reagents, Estimated Market Shares
    U.S.A., Major Suppliers of Clinical Chemistry Analyzers, Estimated Market Shares
    U.S.A., Major Suppliers of Immunodiagnostic Products, Estimated Market Shares
    U.S.A., Major Suppliers of Immunoassay Reagents, Estimated Market Shares
    U.S.A., Major Suppliers of Immunoassay Analyzers, Estimated Market Shares
    Germany, Physician Offices/Group Practices Routine and Special Chemistry Test Volume Forecast
    Germany, Physician Offices/Group Practices Endocrine Function Test Volume Forecast
    Germany, Physician Offices/Group Practices Major Cancer Diagnostic Test Volume Forecast
    Germany, Physician Offices/Group Practices Immunoprotein Test Volume Forecast
    Germany, Physician Offices/Group Practices TDM Test Volume Forecast
    Germany, Physician Offices/Group Practices Routine Chemistry Reagent Market Forecast
    Germany, Physician Offices/Group Practices Cancer Diagnostics Market Forecast by Test
    Germany, Physician Offices/Group Practices Endocrine Function Diagnostics Market Forecast
    Germany, Physician Offices/Group Practices TDM Reagent Market Forecast
    Germany, Physician Offices/Group Practices Immunoprotein Reagent Market Forecast
    Germany, Physician Offices/Group Practices Drugs of Abuse Reagent Market Forecast
    Germany, Major Suppliers of Clinical Chemistry Diagnostic Products Estimated Market Shares
    Germany, Major Suppliers of Clinical Chemistry Reagent Estimated Market Shares
    Germany, Major Suppliers of Clinical Chemistry Analyzers Estimated Market Shares
    Germany, Major Suppliers of Immunodiagnostic Products Estimated Market Shares
    Germany, Major Suppliers of Immunodiagnostic Reagent Estimated Market Shares
    Germany, Major Suppliers of Immunoassay Analyzers Estimated Market Shares
    Spain, Laboratory Performing Chemistry and Immunoassay Tests Forecast by Market Segment
    Spain, Ambulatory Care Centers Routine and Special Chemistry Test Volume Forecast
    Spain, Ambulatory Care Centers Endocrine Function Test Volume Forecast
    Spain, Ambulatory Care Centers TDM Test Volume Forecast
    Spain, Ambulatory Care Centers Immunoprotein Test Volume Forecast
    Spain, Ambulatory Care Centers Drugs of Abuse Test Volume Forecast
    Spain, Ambulatory Care Centers Routine and Special Chemistry Reagent Market Forecast
    Spain, Ambulatory Care Centers Endocrine Function Reagent Market Forecast
    Spain, Ambulatory Care Centers TDM Reagent Market Forecast
    Spain, Ambulatory Care Centers Immunoprotein Reagent Market Forecast
    Spain, Ambulatory Care Centers Drugs of Abuse Reagent Market Forecast
    Spain, Major Suppliers of Clinical Chemistry Diagnostic Products Estimated Market Shares
    Spain, Major Suppliers of Immunodiagnostics Products Estimated Market Shares


    More Publications